Cardiac Education Program for Patients with Myocardial Infarction

effect Cardiac Education Program with Nurse Follow-up on clinical manifestations, laboratory data in patients with myocardial infarction

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201111188124N1

Enrollment

Registered

2014-05-01

Start date

2010-04-04

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myocardial infarction. Ischaemic heart diseases

Interventions

Intervention 1: In the intervention group, the intervention was carried for a period of 3 months with follow up by the nurse in patients with myocardial infarction.The educational content means that a

Rehabilitation

Prevention

In the intervention group, the intervention was carried for a period of 3 months with follow up by the nurse in patients with myocardial infarction.The educational content means that at first, educat

The conventional follow up for patients randomized to the control group consisted of usual outpatient visits (one post treatment visit, then visits at two or three month intervals) by a physician for

Eligibility

Sex/Gender

All

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: All patients<70age? ability to speak? not afflicted with severe and life threatening disease (does not have Ejection Fraction less than 30.0%)? accessibility to telephone? propensity of participating in the research? lack of affliction with uncontrolled diabetes mellitus? hypertension and hyperlipidemia (under treatment) and do not be part of relative treatment-education personnel or member of their families. Exclusion criteria: Lack of cooperation by some of the samples or need to the Coronary Artery Bypass Graft (CABG) during the study

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Triglyceride. Timepoint: Before and three months after the first day of the intervention. Method of measurement: Blood test.;Fasting Blood Sugar. Timepoint: Before and three months after the first day of the intervention. Method of measurement: Blood test.;Clinical manifestation. Timepoint: Before and 3 months after intervention. Method of measurement: Questionner.;Cigarette smoking. Timepoint: three months after the first day of the intervention. Method of measurement: questionnaire.	—

Measure

Time frame

Triglyceride. Timepoint: Before and three months after the first day of the intervention. Method of measurement: Blood test.;Fasting Blood Sugar. Timepoint: Before and three months after the first day of the intervention. Method of measurement: Blood test.;Clinical manifestation. Timepoint: Before and 3 months after intervention. Method of measurement: Questionner.;Cigarette smoking. Timepoint: three months after the first day of the intervention. Method of measurement: questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Molazem

Shiraz university of medical sciences

molazem@sums.ac.ir+98 71 1821 2610

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026